Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Raphael Pharmaceutical (RAPH) posted Liabilities and Shareholders Equity of $7,000 for Q2 2026, down 76.7% from $30,000 a year earlier.

Analysis

Raphael Pharmaceutical (RAPH) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Raphael Pharmaceutical's Liabilities and Shareholders Equity came in at $53,000, up 96.3% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
  • In prior years, Raphael Pharmaceutical's Liabilities and Shareholders Equity was $27,000 in FY2024 (-88.7%), $239,000 in FY2023 (-28.2%), $333,000 in FY2022 (-21.1%) and $422,000 in FY2021 (+30.7%).
  • Quarterly Liabilities and Shareholders Equity has run from a low of $7,000 in Q3 2025 to a high of $422,000 in Q4 2021 over five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in 1 of the last seven quarters, with an average decline of 56.1%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2023, with growth of 233.1%; the weakest was Q4 2024, with a decline of 88.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Raphael Pharmaceutical 28.25 Mn 28.18 Mn - 7,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Dec 31, 2025 53,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 30,000.00
Mar 31, 2025 93,000.00
Dec 31, 2024 27,000.00
Sep 30, 2024 51,000.00
Jun 30, 2024 128,000.00
Mar 31, 2024 353,000.00
Dec 31, 2023 239,000.00
Sep 30, 2023 403,000.00
Jun 30, 2023 119,000.00
Mar 31, 2023 150,000.00
Dec 31, 2022 333,000.00
Sep 30, 2022 121,000.00
Jun 30, 2022 196,000.00
Mar 31, 2022 180,000.00
Dec 31, 2021 422,000.00
Sep 30, 2021 62,000.00
Dec 31, 2020 323,000.00
API Access

Raphael Pharmaceutical Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RAPH&period=max&api_key=YOUR_API_KEY